Why Edema Is a Matter of the Heart.

> I did then what I knew how to do. Now that I know better, I do better. > > —Maya Angelou Myocardial tissue characterization using cardiovascular magnetic resonance (CMR) has become an essential tool for diagnostic and therapeutic decision-making in patients with acute or chronic myocardial disease because it provides unique and relevant information. This is most evident in patients with suspected cardiomyopathy or myocardial involvement in systemic disease, such as amyloidosis, iron overload, or sarcoidosis. Suspected myocarditis is one of the most frequent indications for CMR scans and helps not only by confirming or refuting the disease but can also avoid other, more costly, or invasive diagnostic procedures.1 The established set of CMR criteria for the presence of myocardial inflammation, also known as the Lake Louise Criteria, yield a good diagnostic accuracy with a high negative predictive value.2 Their diagnostic targets are myocardial edema (T2-weighted images), hyperemia/capillary leak (early gadolinium enhancement), and irreversible injury (necrosis, scar; late gadolinium enhancement). Table 1 shows the likelihood of CMR criteria in various settings. View this table: Table 1. Typical Presence of CMR Findings in Patients With Different Forms and Stages of Myocarditis See Article by von Knobelsdorff-Brenkenhoff et al Recently, novel CMR criteria have gained significant interest, especially native T2, native T1, postcontrast T1, and the extracellular volume, the latter being calculated from native and postcontrast T1 mapping results. All these use mapping to measure myocardial proton relaxation times, which reflect tissue pathology and are less sensitive to several problems of signal intensity analyses of single images.3 Myocardial T1 has been found to be altered by …

[1]  P. Kellman,et al.  Detection and Monitoring of Acute Myocarditis Applying Quantitative Cardiovascular Magnetic Resonance , 2017, Circulation. Cardiovascular imaging.

[2]  C. Berry,et al.  Advances in Magnetic Resonance Imaging of the Myocardial Area at Risk and Salvage. , 2016, Circulation. Cardiovascular imaging.

[3]  P. Matthews,et al.  Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping. , 2015, JACC. Cardiovascular imaging.

[4]  M. Mayr,et al.  Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. , 2015, JACC. Cardiovascular imaging.

[5]  M. Friedrich,et al.  Predictive value of CMR criteria for LV functional improvement in patients with acute myocarditis. , 2014, European heart journal cardiovascular Imaging.

[6]  D. Berman,et al.  Determination of Location, Size, and Transmurality of Chronic Myocardial Infarction Without Exogenous Contrast Media by Using Cardiac Magnetic Resonance Imaging at 3 T , 2014, Circulation. Cardiovascular imaging.

[7]  M. Robson,et al.  Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement , 2013, Journal of Cardiovascular Magnetic Resonance.

[8]  E. Nagel,et al.  European cardiovascular magnetic resonance (EuroCMR) registry – multi national results from 57 centers in 15 countries , 2013, Journal of Cardiovascular Magnetic Resonance.

[9]  P. Kellman,et al.  Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. , 2012, JACC. Cardiovascular imaging.

[10]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[11]  S. Iliceto,et al.  Cardiovascular magnetic resonance signs of ischemia in hypertrophic cardiomyopathy. , 2008, International journal of cardiology.

[12]  R. Herfkens,et al.  Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. , 1983, The American journal of cardiology.